ADDvise Group’s interim report for the period July 1 – September 30, 2023 will be published on October 26, 2023 at 07:45 (CEST).
Investors, analysts and other stakeholders are invited to a webcast and conference call at 14:00 (CEST) / 08:00 AM (EST) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will present the report.
Webcast
If you wish to participate via webcast, please use the link below.
https://ir.financialhearings.com/addvise-group-q3-2023
Conference call
If you wish to participate via conference call, please register via the link below. After registration you will receive a phone number and conference ID to access the conference.
https://conference.financialhearings.com/teleconference/?id=5006267
The report and a link to the webcast will be made available on:
https://www.addvisegroup.com/investor-relations/
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
Oliver Humlen, CFO
+46 709-16 26 97
oliver.humlen@addvisegroup.se
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.